Jaafar N. Haidar - Concepedia

Author

Jaafar N. Haidar

Eli Lilly (United States)

Also Known As

Jaafar Haidar, Jaafar N. Haidar, Jaafar N. Sleiman Haidar, Yijun Ruan

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of Massachusetts Chan Medical School Boston University Harvard University Massachusetts General Hospital

About

Jaafar N. Haidar is an author at Eli Lilly (United States) specializing in immunology, autoimmunity, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	30
2	Natural Sciences	1	1	10
3	Biochemistry	1	1	10
4	Biostatistics	1	1	20
5	Cell Biology	1	1	10

Jaafar N. Haidar

Publications

542

Citations

H-Index

Page 1

	Year	Citations
Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen Andrew J. Poole, V. Karuppiah, Annabelle Hartt, Nature Communications	2022	92
Somatostatin Receptor-Specific Analogs: Effects on Cell Proliferation and Growth Hormone Secretion in Human Somatotroph Tumors<sup>1</sup> Daniel C. Danila, Jaafar N. Haidar, Xun Zhang, The Journal of Clinical Endocrinology & Metabolism	2001	84
Structure‐based design of a T‐cell receptor leads to nearly 100‐fold improvement in binding affinity for pepMHC Jaafar N. Haidar, Brian G. Pierce, Yong Yu, Proteins Structure Function and Bioinformatics	2008	72
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity Helen Kotanides, Yiwen Li, Maria Malabunga, Cancer Immunology Research	2020	68
Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance Atrish Bagchi, Jaafar N. Haidar, Scott W. Eastman, Molecular Cancer Therapeutics	2017	55
A universal combinatorial design of antibody framework to graft distinct CDR sequences: A bioinformatics approach Jaafar N. Haidar, Qing‐An Yuan, Lin Zeng, Proteins Structure Function and Bioinformatics	2011	40
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054 Yiwen Li, Carmine Carpenito, George Wang, Journal for ImmunoTherapy of Cancer	2018	30
Overexpression of Wild-Type Activin Receptor Alk4-1 Restores Activin Antiproliferative Effects in Human Pituitary Tumor Cells Daniel C. Danila, Xun Zhang, Yunli Zhou, The Journal of Clinical Endocrinology & Metabolism	2002	26
Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity Helen Kotanides, Rose Marie Sattler, Maria B. Lebron, Molecular Cancer Therapeutics	2020	23
Backbone Flexibility of CDR3 and Immune Recognition of Antigens Jaafar N. Haidar, Wei Zhu, Jacqueline Lypowy, Journal of Molecular Biology	2014	22

Page 1